Why the study?
Do thioridazine hydrochloride and chlorpromazine cause electrocardiographic changes in hospitalized psychiatric patients?
Do thioridazine hydrochloride and chlorpromazine cause electrocardiographic changes in hospitalized psychiatric patients?
T-wave changes associated with thioridazine and chlorpromazine in psychiatric patients are benign and distinct from repolarization duration effects.
T-wave changes with thioridazine appear benign and female-predominant; leaves open need for prospective ECG monitoring studies in psychiatric patients.
Approximately one half of the electrocardiograms of 106 hospitalized psychiatric patients showed the characteristic T-wave changes ascribed to thioridazine hydrochloride. These were more frequent in the female patients and were not related to aging or to the psychiatric diagnosis. Repeat ECGs three months later in 68 of these patients excluded a time-dosage effect and demonstrated some fluctuation of the appearance of the T wave during constant dosage. The U wave does not account for the notched T wave. The survey suggested that the average duration of repolarization varied directly with the degree of morphologic change but further study of 18 patients disclosed that the effect of thioridazine or chlorpromazine on the T wave is distinct from their effect on the duration of repolarization. The study shows that the electrocardiographic changes are benign.
No takes yet. Share an insight, caveat, or question.
John R. Huston (1966) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: